SP

Sitaram Patel

Active Director Director DIN 10282959
DIN 10282959 First appointment Aug 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sitaram Patel

Data last updated:

Sitaram Patel is a Director at Incie Pharma Private Limited (since 2023). The company operates in Paper.

DIN 10282959
Primary Designation Director
Industry Paper
First Appointment 18 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Incie Pharma Private Limited U21009PN2023PTC223218
Director18 Aug 20232023Active

Board colleagues of Sitaram Patel

NameDINCompanyDesignation
Shubham Patel10282960Incie Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Incie Pharma Private Limited
Premium access

Shareholding and investment profile for Sitaram Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sitaram Patel

Sitaram Patel currently holds 1 directorship: Incie Pharma Private Limited (Director, since 18 Aug 2023).

Sitaram Patel was first appointed on 18 Aug 2023 as Director at Incie Pharma Private Limited.

The current boards of Sitaram Patel's companies include Shubham Patel (Incie Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available